Evaluation des attentes en matière de santé d'une population professionnelle universitaire via internet : l'Observatoire de la santé des personnels de l'Université de Lyon 1, une démarche originaleZAMORA, Adeline; CETRE, Jean-Charles; PEROL, David et al.Santé publique (Vandoeuvre-lès-Nancy). 2010, Vol 22, Num 1, pp 37-49, issn 0995-3914, 13 p.Article

Early variations of circulating interleukin-6 and interleukin-10 levels during thoracic radiotherapy are predictive for radiation pneumonitisARPIN, Dominique; PEROL, David; ETIENNE-MASTROIANNI, Bénédicte et al.Journal of clinical oncology. 2005, Vol 23, Num 34, pp 8748-8756, issn 0732-183X, 9 p.Article

Randomized, Phase III Study of Gemcitabine or Erlotinib Maintenance Therapy Versus Observation, With Predefined Second-Line Treatment, After Cisplatin-Gemcitabine Induction Chemotherapy in Advanced Non―Small-Cell Lung CancerPEROL, Maurice; CHOUAID, Christos; MONNET, Isabelle et al.Journal of clinical oncology. 2012, Vol 30, Num 28, pp 3516-3524, issn 0732-183X, 9 p.Article

Lymphopenia as a Prognostic Factor for Overall Survival in Advanced Carcinomas, Sarcomas, and LymphomasRAY-COQUARD, Isabelle; CROPET, Claire; GUASTAILA, Jean-Paul et al.Cancer research (Chicago, Ill.). 2009, Vol 69, Num 13, pp 5383-5391, issn 0008-5472, 9 p.Article

Time-to-event analysis with artificial neural networks: An integrated analytical and rule-based study for breast cancerLISBOA, Paulo J. G; ETCHELLS, Terence A; NEGRIER, Sylvie et al.Neural networks. 2008, Vol 21, Num 2-3, pp 414-426, issn 0893-6080, 13 p.Conference Paper

L'éducation thérapeutique en cancérologie : vers une reconnaissance des compétences du patient = Therapeutic education in oncology : involving patient in the management of cancerPEROL, David; TOUTENU, Pauline; LEFRANC, Anne et al.Bulletin du cancer. 2007, Vol 94, Num 3, pp 267-274, issn 0007-4551, 8 p.Article

Quality of life in geriatric oncology: An evaluation of standard questionnaires in elderly men with urological malignanciesTERRET, Catherine; PEROL, David; ALBRAND, Gilles et al.Critical reviews in oncology/hematology. 2011, Vol 77, Num 3, pp 201-209, issn 1040-8428, 9 p.Article

Customized Adjuvant Phase II Trial in Patients With Non-Small-Cell Lung Cancer: IFCT-0801 TASTEWISLEZ, Marie; BARLESI, Fabrice; RENAULT, Aldo et al.Journal of clinical oncology. 2014, Vol 32, Num 12, pp 1256-1261, issn 0732-183X, 6 p.Article

Prognostic Value of Serum CA9 in Patients with Metastatic Clear Cell Renal Cell Carcinoma under Targeted TherapyGIGANTE, Marc; LI, Guorong; GENIN, Christian et al.Anticancer research. 2012, Vol 32, Num 12, pp 5447-5451, issn 0250-7005, 5 p.Article

Final Results of ERASME-4: A Randomized Trial of First-Line Docetaxel plus either Capecitabine or Epirubicin for Metastatic Breast CancerBACHELOT, Thomas; BAJARD, Agathe; FERRI-DESSENS, Rose-Marie et al.Oncology. 2011, Vol 80, Num 3-4, pp 262-268, issn 0030-2414, 7 p.Article

Revisiting the level of evidence in randomized controlled clinical trials: A simulation approachBAJARD, Agathe; CHABAUD, Sylvie; PEROL, David et al.Contemporary clinical trials. 2009, Vol 30, Num 5, pp 400-410, issn 1551-7144, 11 p.Article

Medroxyprogesterone, interferon alfa-2a, interleukin 2, or combination of both cytokines in patients with metastatic renal carcinoma of intermediate prognosis : Results of a randomized controlled trialNEGRIER, Sylvie; PEROL, David; RAVAUD, Alain et al.Cancer. 2007, Vol 110, Num 11, pp 2468-2477, issn 0008-543X, 10 p.Article

La réglette EVA : un outil de médiation dans la relation soignant-malade ? Étude sociologique réalisée dans deux centres spécialisés dans le traitement du cancer de la région Rhône-Alpes = The visual analog scale : A mediation tool for patient-caregiver communication. A sociological study conducted in two cancer centers in the Rhône-Alpes regionREGNIER, Véronique; LEFRANC, Anne; CHVETZOFF, Gisèle et al.Douleurs (Paris). 2008, Vol 9, Num 4, pp 202-210, issn 1624-5687, 9 p.Article

Méthodologie des essais cliniques en cancérologie : médicaments anticancéreux (2e partie) = Design of clinical trials in oncologyTRANCHAND, Brigitte; CHABAUD, Sylvie; COLOMBAN, Olivier et al.La Lettre du pharmacologue (Boulogne). 2008, Vol 22, Num 3, pp 98-110, issn 0984-452X, 13 p.Article

A phase-III trial of doxorubicin and docetaxel versus doxorubicin and paclitaxel in metastatic breast cancer : results of the ERASME 3 studyCASSIER, Philippe A; CHABAUD, Sylvie; AGOSTINI, Cecile et al.Breast cancer research and treatment. 2008, Vol 109, Num 2, pp 343-350, issn 0167-6806, 8 p.Article

Randomized Study of Intravenous versus Subcutaneous Interleukin-2, and IFNα in Patients with Good Prognosis Metastatic Renal CancerNEGRIER, Sylvie; PEROL, David; ESCUDIER, Bernard et al.Clinical cancer research (Print). 2008, Vol 14, Num 18, pp 5907-5912, issn 1078-0432, 6 p.Article

Is There a Role for Pelvic Irradiation in Localized Prostate Adenocarcinoma? Preliminary Results of GETUG-01POMMIER, Pascal; CHABAUD, Sylvie; PABOT DU CHATELARD, Pierre Marie et al.Journal of clinical oncology. 2007, Vol 25, Num 34, pp 5366-5373, issn 0732-183X, 8 p.Article

Prognostic factors of response or failure of treatment in patients with metastatic renal carcinomas treated by cytokines : a report from the Groupe Français d'immunothérapieNEGRIER, Sylvie; GOMEZ, Frédéric; DOUILLARD, Jean-Yves et al.World journal of urology (Print). 2005, Vol 23, Num 3, pp 161-165, issn 0724-4983, 5 p.Article

Interleukin-6, interleukin-10, and vascular endothelial growth factor in metastatic renal cell carcinoma: Prognostic value of interleukin-6-from the groupe français d'immunothérapieNEGRIER, Sylvie; PEROL, David; MENETRIER-CAUX, Christine et al.Journal of clinical oncology. 2004, Vol 22, Num 12, pp 2371-2378, issn 0732-183X, 8 p.Article

Prospective evaluation of early lung toxicity following three-dimensional conformal radiation therapy in non-small-cell lung cancer : Preliminary resultsSUNYACH, Marie-Pierre; FALCHERO, Lionel; PEROL, David et al.International journal of radiation oncology, biology, physics. 2000, Vol 48, Num 2, pp 459-463, issn 0360-3016Conference Paper

Pharmacokinetics of pazopanib administered in combination with bevacizumabIMBS, Diane-Charlotte; NEGRIER, Sylvie; CHATELUT, Etienne et al.Cancer chemotherapy and pharmacology. 2014, Vol 73, Num 6, pp 1189-1196, issn 0344-5704, 8 p.Article

Chemotherapy for metastatic breast cancer. Comparison of clinical practice and cost of drugs in two cohorts of patients: 1994―1998 and 2003―2006GALY, Guillaume; INTIDHAR LABIDI-GALY, Sana; FAVIER, Bertrand et al.Breast cancer research and treatment. 2011, Vol 128, Num 1, pp 187-195, issn 0167-6806, 9 p.Article

Body weight change in women receiving adjuvant chemotherapy for breast cancer: A French prospective studyTREDAN, Olivier; BAJARD, Agathe; PEROL, David et al.Clinical nutrition (Edinburgh). 2010, Vol 29, Num 2, pp 187-191, issn 0261-5614, 5 p.Article

Time-to-event analysis with artificial neural networks : An integrated analytical and rule-based study for breast cancerLISBOA, Paulo J. G; ETCHELLS, Terence A; NEGRIER, Sylvie et al.Neural networks. 2008, Vol 21, Num 2-3, pp 427-436, issn 0893-6080, 10 p.Conference Paper

Étude prospective de qualité des soins et de qualité de vie chez des patients cancéreux en phase palliative, en hospitalisation ou à domicile : analyse intermédiaire de l'étude Trapado = Prospective study on the quality of care and quality of life in advanced cancer patients treated at home or in hospital : intermediate analysis of the Trapado studyCHVETZOFF, Gisèle; PEROL, David; GOBET, Sophie et al.Bulletin du cancer. 2006, Vol 93, Num 2, pp 213-221, issn 0007-4551, 9 p.Article